Stock A009290 KWANG DONG PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kwang Dong Pharmaceutical Co., Ltd.

Equities

A009290

KR7009290008

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-07-04 pm EDT 		5-day change 1st Jan Change
6,450 KRW +0.31% Intraday chart for Kwang Dong Pharmaceutical Co., Ltd. +0.16% -13.19%
Jul. 02 Kwang Dong Pharmaceutical Co., Ltd. agreed to acquire 29.7% stake in Precision Biosensor, Inc. from i-SENS, Inc. from Cha, Geun Sik, Nam Hak-hyeon and Yoon Jongwoo for KRW 16.9 billion. CI
May. 16 Kwang Dong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 277,977 263,211 421,076 305,229 244,840 297,799
Enterprise Value (EV) 1 258,924 263,357 381,508 249,574 174,214 327,259
P/E ratio 12.4 x 11.4 x 9.16 x 12.7 x 10.1 x 8.14 x
Yield 1.17% 1.2% 0.98% 1.35% 1.68% 1.35%
Capitalization / Revenue 0.24 x 0.21 x 0.34 x 0.23 x 0.17 x 0.2 x
EV / Revenue 0.22 x 0.21 x 0.31 x 0.19 x 0.12 x 0.22 x
EV / EBITDA 5.04 x 4.35 x 5.75 x 4.23 x 3.33 x 5.95 x
EV / FCF 7.81 x 15.8 x -21.5 x 4.19 x 4.92 x -5.58 x
FCF Yield 12.8% 6.33% -4.66% 23.9% 20.3% -17.9%
Price to Book 0.68 x 0.62 x 0.88 x 0.61 x 0.47 x 0.55 x
Nbr of stocks (in thousands) 40,581 39,581 41,081 41,081 41,081 40,081
Reference price 2 6,850 6,650 10,250 7,430 5,960 7,430
Announcement Date 3/21/19 3/12/20 3/18/21 3/17/22 3/16/23 3/18/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 1,180,220 1,238,255 1,243,770 1,338,182 1,431,545 1,514,454
EBITDA 1 51,397 60,605 66,299 59,045 52,262 54,974
EBIT 1 33,945 41,803 46,591 44,936 38,244 42,070
Operating Margin 2.88% 3.38% 3.75% 3.36% 2.67% 2.78%
Earnings before Tax (EBT) 1 31,396 36,770 62,951 34,329 36,291 49,019
Net income 1 22,345 23,058 45,370 24,019 24,174 36,966
Net margin 1.89% 1.86% 3.65% 1.79% 1.69% 2.44%
EPS 2 550.8 581.7 1,119 584.3 588.0 913.0
Free Cash Flow 1 33,171 16,665 -17,775 59,535 35,407 -58,701
FCF margin 2.81% 1.35% -1.43% 4.45% 2.47% -3.88%
FCF Conversion (EBITDA) 64.54% 27.5% - 100.83% 67.75% -
FCF Conversion (Net income) 148.45% 72.27% - 247.87% 146.47% -
Dividend per Share 2 80.00 80.00 100.0 100.0 100.0 100.0
Announcement Date 3/21/19 3/12/20 3/18/21 3/17/22 3/16/23 3/18/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 146 - - - 29,460
Net Cash position 1 19,054 - 39,568 55,655 70,627 -
Leverage (Debt/EBITDA) - 0.002416 x - - - 0.5359 x
Free Cash Flow 1 33,171 16,665 -17,775 59,535 35,407 -58,701
ROE (net income / shareholders' equity) 5.19% 5.16% 9.6% 4.96% 4.97% 6.94%
ROA (Net income/ Total Assets) 2.92% 3.43% 3.59% 3.28% 2.63% 2.62%
Assets 1 766,106 672,882 1,264,733 733,160 918,253 1,413,003
Book Value Per Share 2 10,087 10,686 11,627 12,151 12,593 13,588
Cash Flow per Share 2 1,679 1,927 1,336 2,044 2,521 1,930
Capex 1 18,827 12,637 5,262 23,795 25,383 34,785
Capex / Sales 1.6% 1.02% 0.42% 1.78% 1.77% 2.3%
Announcement Date 3/21/19 3/12/20 3/18/21 3/17/22 3/16/23 3/18/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Generic Pharmaceuticals

1st Jan change Capi.
KWANG DONG PHARMACEUTICAL CO., LTD. Stock Kwang Dong Pharmaceutical Co., Ltd.
-13.19% 187M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+24.53% 45.07B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+30.99% 23.39B
SANDOZ GROUP AG Stock Sandoz Group AG
+24.13% 16.08B
CIPLA LIMITED Stock Cipla Limited
+21.15% 14.6B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+68.67% 14.01B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-13.29% 6.38B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+13.53% 5.64B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A009290 Stock
  4. Financials Kwang Dong Pharmaceutical Co., Ltd.